{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:29:19Z","timestamp":1793917759602,"version":"4.8.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences","doi-asserted-by":"publisher","award":["53161"],"award-info":[{"award-number":["53161"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jocn-journal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jocn.2024.110845","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T11:53:55Z","timestamp":1727697235000},"page":"110845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The effect of a nicotine-rich diet with\/without redistribution of dietary protein on motor indices in patients with Parkinson\u2019s disease: A randomized clinical trial"],"prefix":"10.1016","volume":"129","author":[{"given":"Hamid","family":"Lorvand Amiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Hassan Javanbakht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed","family":"Mohammad Baghbanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboubeh","family":"Parsaeian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2024.110845_b0005","series-title":"Understanding and treating freezing of gait in parkinsonism, proposed working definition, and setting the stage","first-page":"S423","author":"Giladi","year":"2008"},{"key":"10.1016\/j.jocn.2024.110845_b0010","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00415-004-0483-3","article-title":"Psychiatric aspects of Parkinson\u2019s disease: an update","volume":"251","author":"Schrag","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2024.110845_b0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1468-1331.2008.02056.x","article-title":"Non-motor symptoms in Parkinson\u2019s disease","volume":"15","author":"Poewe","year":"2008","journal-title":"Eur J Neurol"},{"issue":"5","key":"10.1016\/j.jocn.2024.110845_b0020","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.clineuro.2008.11.019","article-title":"The relation of testosterone levels with fatigue and apathy in Parkinson's disease","volume":"111","author":"Kenangil","year":"2009","journal-title":"Clin Neurol Neurosurg"},{"issue":"5","key":"10.1016\/j.jocn.2024.110845_b0025","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.neuint.2012.12.016","article-title":"Neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson\u2019s disease","volume":"62","author":"Taylor","year":"2013","journal-title":"Neurochem Int"},{"key":"10.1016\/j.jocn.2024.110845_b0030","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00702-005-0427-9","article-title":"The plasma alpha-synuclein levels in patients with Parkinson\u2019s disease and multiple system atrophy","volume":"113","author":"Lee","year":"2006","journal-title":"J Neural Transm"},{"issue":"9","key":"10.1016\/j.jocn.2024.110845_b0035","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3109\/00207454.2014.961454","article-title":"Cerebrospinal fluid alpha-synuclein as a biomarker for Parkinson's disease diagnosis: a systematic review and meta-analysis","volume":"125","author":"Gao","year":"2015","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.jocn.2024.110845_b0040","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00702-016-1650-2","article-title":"Relationship between the plasma levels of neurodegenerative proteins and motor subtypes of Parkinson\u2019s disease","volume":"124","author":"Ding","year":"2017","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jocn.2024.110845_b0045","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3389\/fneur.2019.01388","article-title":"Plasma and serum alpha-synuclein as a biomarker of diagnosis in patients with Parkinson's disease","volume":"10","author":"Chang","year":"2020","journal-title":"Front Neurol"},{"issue":"6","key":"10.1016\/j.jocn.2024.110845_b0050","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.10028","article-title":"Cigarette smoking and the incidence of Parkinson's disease in two prospective studies","volume":"50","author":"Hern\u00e1n","year":"2001","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.jocn.2024.110845_b0055","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.10277","article-title":"A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease","volume":"52","author":"Hern\u00e1n","year":"2002","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.jocn.2024.110845_b0060","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1001\/archneur.64.7.990","article-title":"Pooled analysis of tobacco use and risk of Parkinson disease","volume":"64","author":"Ritz","year":"2007","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.jocn.2024.110845_b0065","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.archger.2015.08.004","article-title":"Association between cigarette smoking and Parkinson\u2019s disease: a meta-analysis","volume":"61","author":"Li","year":"2015","journal-title":"Arch Gerontol Geriatr"},{"issue":"9","key":"10.1016\/j.jocn.2024.110845_b0070","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1212\/WNL.55.9.1350","article-title":"Smoking, alcohol, and coffee consumption preceding Parkinson\u2019s disease: a case-control study","volume":"55","author":"Benedetti","year":"2000","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.jocn.2024.110845_b0075","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/mds.20587","article-title":"Smokeless tobacco use and the risk of Parkinson's disease mortality","volume":"20","author":"O'Reilly","year":"2005","journal-title":"Move Disord"},{"issue":"2","key":"10.1016\/j.jocn.2024.110845_b0080","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/mds.24012","article-title":"Environmental tobacco smoke and Parkinson's disease","volume":"27","author":"Searles Nielsen","year":"2012","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.jocn.2024.110845_b0085","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/aje\/kwn388","article-title":"Smoking and Parkinson's disease: using parental smoking as a proxy to explore causality","volume":"169","author":"O'Reilly","year":"2009","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.jocn.2024.110845_b0090","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1212\/01.wnl.0000223618.53129.56","article-title":"Passive smoking and Parkinson disease","volume":"67","author":"Mellick","year":"2006","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jocn.2024.110845_b0095","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/ajcn\/nqaa186","article-title":"Dietary nicotine intake and risk of Parkinson disease: a prospective study","volume":"112","author":"Ma","year":"2020","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"10.1016\/j.jocn.2024.110845_b0100","first-page":"905","article-title":"(S)-(\u2212)-Cotinine, the major brain metabolite of nicotine, stimulates nicotinic receptors to evoke [3H] dopamine release from rat striatal slices in a calcium-dependent manner","volume":"288","author":"Dwoskin","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.jocn.2024.110845_b0105","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1471-4159.2001.00019.x","article-title":"Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum","volume":"76","author":"Grady","year":"2001","journal-title":"J Neurochem"},{"issue":"3","key":"10.1016\/j.jocn.2024.110845_b0110","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0091-3057(94)90097-3","article-title":"Benzodiazepine receptor mediation of the anxiolytic-like effect of (\u2212)-nicotine in mice","volume":"49","author":"O'Neill","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"issue":"16","key":"10.1016\/j.jocn.2024.110845_b0115","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/jama.2014.3654","article-title":"Pharmacological treatment of Parkinson disease: a review","volume":"311","author":"Connolly","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jocn.2024.110845_b0120","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/mds.26082","article-title":"Levodopa therapy for Parkinson's disease: pharmacokinetics and pharmacodynamics","volume":"30","author":"LeWitt","year":"2015","journal-title":"Mov Disord"},{"key":"10.1016\/j.jocn.2024.110845_b0125","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2165\/00023210-200721080-00005","article-title":"Medical management of levodopa-associated motor complications in patients with Parkinson\u2019s disease","volume":"21","author":"Jankovic","year":"2007","journal-title":"CNS Drugs"},{"issue":"9996","key":"10.1016\/j.jocn.2024.110845_b0130","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2024.110845_b0135","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00415-010-5728-8","article-title":"Pharmacokinetics of levodopa","volume":"257","author":"Contin","year":"2010","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.jocn.2024.110845_b0140","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2174\/157488407781668802","article-title":"The pharmacokinetics and pharmacodynamics of levodopa in the treatment of Parkinson's disease","volume":"2","author":"Khor","year":"2007","journal-title":"Curr Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.jocn.2024.110845_b0145","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1001\/archneur.1987.00520150026014","article-title":"Influence of dietary protein on motor fluctuations in Parkinson's disease","volume":"44","author":"Pincus","year":"1987","journal-title":"Arch Neurol"},{"issue":"7","key":"10.1016\/j.jocn.2024.110845_b0150","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1212\/WNL.38.7.1026","article-title":"Practical application of a low-protein diet for Parkinson's disease","volume":"38","author":"Riley","year":"1988","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jocn.2024.110845_b0155","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jnnp.52.4.481","article-title":"Influence of fluctuations of plasma large neutral amino acids with normal diets on the clinical response to levodopa","volume":"52","author":"Nutt","year":"1989","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.jocn.2024.110845_b0160","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000116649","article-title":"Protein redistribution diet and antiparkinsonian response to levodopa","volume":"31","author":"Bracco","year":"1991","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jocn.2024.110845_b0165","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/BF00839148","article-title":"An international comparison of dietary protein consumption and mortality from Parkinson's disease","volume":"239","author":"Coughlin","year":"1992","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.jocn.2024.110845_b0170","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/ajcn\/55.3.701","article-title":"Effect of daytime protein restriction on nutrient intakes of free-living Parkinson's disease patients","volume":"55","author":"Pare","year":"1992","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"10.1016\/j.jocn.2024.110845_b0175","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord"},{"issue":"12","key":"10.1016\/j.jocn.2024.110845_b0180","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/j.1468-1331.2007.01949.x","article-title":"Chronic high dose transdermal nicotine in Parkinson's disease: an open trial","volume":"14","author":"Villafane","year":"2007","journal-title":"Eur J Neurol"},{"issue":"8","key":"10.1016\/j.jocn.2024.110845_b0185","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1021\/jf990089w","article-title":"Determination of the nicotine content of various edible nightshades (Solanaceae) and their products and estimation of the associated dietary nicotine intake","volume":"47","author":"Siegmund","year":"1999","journal-title":"J Agric Food Chem"},{"issue":"8","key":"10.1016\/j.jocn.2024.110845_b0190","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archpsyc.63.8.907","article-title":"Cigarette smoking saturates brain \u03b14\u03b22 nicotinic acetylcholine receptors","volume":"63","author":"Brody","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"12","key":"10.1016\/j.jocn.2024.110845_b0195","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.amjcard.2009.02.018","article-title":"Effect of the site of measurement of waist circumference on the prevalence of the metabolic syndrome","volume":"103","author":"Mason","year":"2009","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.jocn.2024.110845_b0200","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/mds.21198","article-title":"Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): process, format, and clinimetric testing plan","volume":"22","author":"Goetz","year":"2007","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.jocn.2024.110845_b0205","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1471-4159.1990.tb02341.x","article-title":"Nicotinic modulation of [3H] dopamine release from striatal synaptosomes: pharmacological characterisation","volume":"54","author":"Rapier","year":"1990","journal-title":"J Neurochem"},{"issue":"3","key":"10.1016\/j.jocn.2024.110845_b0210","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1471-4159.1992.tb08322.x","article-title":"Characterization of nicotinic receptor-mediated [3H] dopamine release from synaptosomes prepared from mouse striatum","volume":"59","author":"Grady","year":"1992","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.jocn.2024.110845_b0215","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1056\/NEJM197501232920404","article-title":"Protein intake and treatment of Parkinson's disease with levodopa","volume":"292","author":"Mena","year":"1975","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jocn.2024.110845_b0220","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1212\/WNL.39.4.552","article-title":"Amount and distribution of dietary protein affects clinical response to levodopa in Parkinson's disease","volume":"39","author":"Carter","year":"1989","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jocn.2024.110845_b0225","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.clnu.2008.06.008","article-title":"Optimal protein intake in the elderly","volume":"27","author":"Wolfe","year":"2008","journal-title":"Clin Nutr"},{"issue":"6","key":"10.1016\/j.jocn.2024.110845_b0230","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/gerona\/gls229","article-title":"Is the optimal level of protein intake for older adults greater than the recommended dietary allowance?","volume":"68","author":"Volpi","year":"2013","journal-title":"J Gerontol Series A: Biomed Sci Med Sci"},{"issue":"11","key":"10.1016\/j.jocn.2024.110845_b0235","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/mds.21068","article-title":"Body weight in patients with Parkinson's disease","volume":"21","author":"Bachmann","year":"2006","journal-title":"Move Disord"},{"key":"10.1016\/j.jocn.2024.110845_b0240","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.parkreldis.2020.06.015","article-title":"Progressive and accelerated weight and body fat loss in Parkinson's disease: A three-year prospective longitudinal study","volume":"77","author":"Yong","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"10.1016\/j.jocn.2024.110845_b0245","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.23872","article-title":"Plasma apolipoprotein A1 as a biomarker for Parkinson disease","volume":"74","author":"Qiang","year":"2013","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1016\/j.jocn.2024.110845_b0250","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/mds.26290","article-title":"Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson's disease patients","volume":"30","author":"Swanson","year":"2015","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.jocn.2024.110845_b0255","doi-asserted-by":"crossref","first-page":"R1382","DOI":"10.1152\/ajpregu.2001.280.5.R1382","article-title":"Intestinal satiety protein apolipoprotein AIV is synthesized and regulated in rat hypothalamus","volume":"280","author":"Liu","year":"2001","journal-title":"Am J Physiol-Regul, Integr Comp Physiol"},{"issue":"12","key":"10.1016\/j.jocn.2024.110845_b0260","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1210\/en.2012-1427","article-title":"Apolipoprotein AIV requires cholecystokinin and vagal nerves to suppress food intake","volume":"153","author":"Lo","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.jocn.2024.110845_b0265","doi-asserted-by":"crossref","unstructured":"Kardani J, Sethi R, Roy I. Nicotine slows down oligomerisation of \u03b1-synuclein and ameliorates cytotoxicity in a yeast model of Parkinson's disease. Biochim Biophys Acta (BBA)-Mol Basis Dis, 2017;1863(6): 1454-1463.","DOI":"10.1016\/j.bbadis.2017.02.002"},{"key":"10.1016\/j.jocn.2024.110845_b0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2019.04.017","article-title":"Nicotine prevents alpha-synuclein accumulation in mouse and human iPSC-derived dopaminergic neurons through activation of the dopamine D3-acetylcholine nicotinic receptor heteromer","volume":"129","author":"Bono","year":"2019","journal-title":"Neurobiol Dis"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586824003849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586824003849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T13:39:21Z","timestamp":1731418761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586824003849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":54,"alternative-id":["S0967586824003849"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2024.110845","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of a nicotine-rich diet with\/without redistribution of dietary protein on motor indices in patients with Parkinson\u2019s disease: A randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2024.110845","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110845"}}